Rantzwiller, France

Sebastien Ripoche

USPTO Granted Patents = 4 

Average Co-Inventor Count = 14.2

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2016-2019

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: The Innovative Journey of Sebastien Ripoche

Introduction: Sebastien Ripoche, an accomplished inventor based in Rantzwiller, France, has made significant contributions to the field of pharmaceuticals with a focus on innovative therapeutic compounds. With four patents to his name, Ripoche is known for his work on compounds that effectively inhibit FGFR4, a key target in cancer treatments.

Latest Patents: Sebastien Ripoche's latest patents include the following noteworthy inventions:

1. **Use of Ring-Fused Bicyclic Pyridyl Derivatives as FGFR4 Inhibitors** - This patent relates to the therapeutic uses of compounds represented by a specific formula or its pharmaceutically acceptable salts.

2. **Ring-Fused Bicyclic Pyridyl Derivatives as FGFR4 Inhibitors** - This invention not only provides the composition of the compound but also describes a method for manufacturing said compound, highlighting its therapeutic applications. Additionally, it introduces a combination of pharmacologically active agents and a pharmaceutical composition containing the compound.

Career Highlights: Ripoche has been instrumental in advancing drug development at Novartis AG, a global leader in the pharmaceutical industry. His innovative work focuses on harnessing the potential of bicyclic derivatives for medical treatment, streamlining pathways to breakthrough therapies.

Collaborations: Throughout his career, Sebastien Ripoche has collaborated with talented colleagues such as Nicole Buschmann and Robin Alec Fairhurst, enhancing the innovation process and driving groundbreaking research initiatives.

Conclusion: Sebastien Ripoche's contributions to the medical field showcase the importance of innovation in developing effective therapeutic solutions. His patents reflect a commitment to improving cancer treatment options, demonstrating the potential of scientific research and collaboration in making a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…